Health ❯ Vaccines

mRNA Vaccines

COVID-19 Vaccines Vaccine Development Public Health Research and Development Development Pandemic Preparedness Infectious Diseases Flu Vaccines COVID-19 Covid-19 mRNA Vaccine Technology Bird Flu Vaccine Moderna and Pfizer Influenza Vaccines Funding Public Health Policy COVID-19 mRNA Vaccines Research Funding Safety and Efficacy Cancer Treatment Vaccine Safety Norovirus Vaccine Research Public Trust HIV Vaccine Research Lipid Nanoparticles Vaccine Skepticism Pfizer Pfizer Vaccine Bird Flu Vaccines Covid-19 Vaccines Virus-like Nanoparticles Myocarditis Clinical Trials Venture Financing Combination Vaccines Pandemic Influenza Psychological Factors Safety Concerns mRNA Vaccine Safety mRNA Vaccine Development mRNA Vaccine Efficacy mRNA Vaccine Trust mRNA Covid boosters Benefits DNA Contamination DNA Fragments Respiratory Illnesses Gemcovac-19 Safety Antigenic Shift and Drift Vaccine Research Efficacy Vaccine Technology Vaccine Efficacy Effectiveness

Study Pinpoints Immune Signals Behind Rare Myocarditis After mRNA COVID Vaccines

Preclinical work ties CXCL10 plus interferon gamma to cardiac injury, pointing to cytokine blockers or genistein as possible mitigations.

Pfizer’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

Lipid Nanoparticle Cargo, Not the Shell, Drives Dendritic Cell Fate, Belgian Study Finds

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

US Cuts $500 Million in mRNA Vaccine Research Funding

HHS Cancels $500M in mRNA Vaccine Contracts, Winding Down Respiratory Virus Efforts

RFK Jr. Terminates $500 Million in BARDA mRNA Vaccine Projects as Experts Warn of Consequences

HHS Withdraws $500 Million for mRNA Vaccine Research as Experts Warn of Pandemic Risks

Kennedy Halts $500 Million in mRNA Vaccine Contracts, Shifts Investment to Alternative Platforms

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval

Trump Administration Cuts Moderna Funding and Disbands mRNA Vaccine Panel

HHS Withdraws $766 Million for Moderna’s Bird Flu mRNA Vaccine

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

HHS Withdraws $766 Million From Moderna’s Bird Flu Vaccine Program